Use of Others' Trademarks As Meta Tags Found to Be Intent to Cause Confusion in a Trademark Infringement Case

Download IconDownload Print IconPrint

Use of Others' Trademarks As Meta Tags Found to Be Intent to Cause Confusion in a Trademark Infringement Case

Publication

Related Solutions

We help companies protect data, comply with evolving regulations, and respond to investigations and litigation.
Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Our clients in the ever-changing and fiercely competitive hardware, software, IT and services industries depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and preserving flexibility for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale’s unique capabilities in regulatory, intellectual property, corporate and tax law. We represent both mature and emerging companies with business models centered around offering software and/or professional services relating to analyzing and extracting insights from large data sets. We frequently draft and negotiate data license agreements, software-as-a-service (SaaS) agreements, website terms and other services agreements in which data is the core subject of the license. We also advise technology clients on big data issues that arise in outsourcing, joint venture and other transactional matters. Our attorneys keep a close watch on internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.

In a case that has significant ramifications for companies that use the trademarks of others in their metatags to attract hits to their web sites, the Seventh Circuit has held that use of third party trademarks as a meta tag can demonstrate an "intent to cause confusion" in a trademark infringement case.

Meta tags are html code that are often used to describe the subject matter of a web site. Most Internet search engines search the meta tag field when conducting searches. A web site may therefore attract hits by placing terms within its meta tags, even if such terms are not used in or relevant to the web site.

In Eli Lilly & Company v. Natural Answers, Incorporated (No. 00-1375 (7th Cir. 11/21/2000)), Eli Lilly, as owner of the trademark "Prozac," brought suit against Natural Answers for trademark infringement, trademark dilution and violations of state unfair competition laws due to Natural Answers’ use of the term "Herbrozac" for a herbal supplement. Natural Answers marketed Herbrozac as a mood-enhancing herbal supplement. In addition to its use of "Herbrozac" as a brand name, Natural Answers also used the term "Prozac" in the meta tags to its web site, though "Prozac" did not appear on the web site itself.

While noting that the effort to use "Prozac" in the metatag to attract traffic to its web site was a failure from Natural Answers’ perspective because Internet searchers were overwhelmed with sites related to Prozac, the court found that Natural Answers’ use of the term "Prozac" in its metatags was "probative of wrongful intent [to confuse consumers]" and that such use of another’s trademark is "significant evidence of intent to confuse and mislead." Use of the trademark of another in a meta tag can clearly demonstrate an intent to confuse consumers, which is a required element of any trademark infringement claim.

Companies and individuals with web sites that use the trademarks of third parties in metatags must be cognizant of the heightened risks of trademark infringement. Many web site operators have assumed that by avoiding use of a trademark in the text of a web site, they are avoiding liability for trademark infringement. Although some cases have gone the other way, Eli Lilly demonstrates that use of a trademark in a meta tag can, at the least, be a significant factor in finding trademark infringement under certain circumstances.

 

Michael Bevilacqua
[email protected]

 

Jeffrey Johnson
[email protected]

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel